Postdoctoral Research Fellowship: Modulating TH17/Treg balance in immune-mediated arthritis

University of Oxford


Hussein Al-MossawiNIHR Clinical Lecturer in Rheumatology
Paul BownessProfessor of Experimental Rheumatology


The type 17/23 axis plays a key role in the pathogenesis of Ankylosing Spondylitis and realted human diseases including Psoriatic Arthritis, Psoriasis and Inflammatory Bowel Disease. Understanding the immune pathogenesis of Type17 responses in AS has opened up opportunities for more effective targeted therapy. This project will take candidates from novel datasets (eg RNA seq) obtained from type 17 cells AS, and address their potential pathogenicity.

We have previously shown using in vitro assays with patient-derived cells that small molecule inhibitors of ERAP1, of the transcription factor ROR gamma T, of the (epigenetic) bromodomain readers and transcriptional co-activators CBP and p300 and of JAKs can all inhibit Type17 responses in vitro.

We will also luse established immunological assays to look for evidence of reciprocal regulation of regulatory T cell responses in SpA.


The Botnar Research Centre plays host to the University of Oxford's Institute of Musculoskeletal Sciences, which enables and encourages research and education into the causes of musculoskeletal disease and their treatment. Training will be provided in techniques including FACS and FACS analysis, cell culture, immunoassays, bacterial culture and metagenome analysis.


Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:


South East England